18 news items
Soligenix Announces Reverse Stock Split
SNGX
31 May 24
as ThermoVax®. To date, this business segment has been supported with government grant and contract funding from the National
Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
SNGX
29 May 24
as ThermoVax®. To date, this business segment has been supported with government grant and contract funding from the National Institute
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
SNGX
24 May 24
. To date, this business segment has been supported with government grant and contract funding from the National Institute of Allergy and Infectious
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
SNGX
23 May 24
government funding to build shareholder value," stated Christopher J. Schaber, PhD
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
SNGX
21 May 24
of the company's proprietary heat stabilization platform technology, ThermoVax®. This business segment has received support from government grant
7d8vxu7f9b19g5h2 2hxxu28a9k4e8nqjus2bcbc5nhjrpe42xuy0
SNGX
21 May 24
needs. The conference offers high-quality scientific content from leaders in academia, industry, government and not-for-profit global health
cw8tbz3d9dhcmgses5t4w3jjxc7iaqj3jr5pjw0uk7lw8cv6bdosb9pf
SNGX
20 May 24
as ThermoVax®. To date, this business segment has been supported with government grant and contract funding from the National Institute
7uq3rcay02elhz6xknk02aaljqrqdz7y525
SNGX
16 May 24
as ThermoVax®. To date, this business segment has been supported with government grant and contract funding from the National Institute
55f4cho8 qhsdx
SNGX
10 May 24
million in net proceeds from our recent financing and our non-dilutive government funding, we continue to manage cash burn very carefully to achieve
7dphwjyt1m4icgt22p0ck3jinj8jj lvg4ran51u2csltrnaq9s2b
SNGX
6 May 24
supported with government grant and contract funding from the National Institute of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction
i419fppu0fjjatylxankui3faqlgwm5rhp22bpuaf
SNGX
25 Apr 24
a wide range of financial and regulatory benefits, including government grants for conducting clinical trials, waiver of expensive FDA user fees
qz5iei
SNGX
18 Apr 24
with government grant and contract funding from the National Institute of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction
tiafm0kwxafivbikinocxlyv5stqo
SNGX
16 Apr 24
. In addition, financial and regulatory benefits are available including government grants to conduct clinical trials, waiver of FDA user fees, and certain
lrvq43lo6fhjmyqtf2 kp0
SNGX
15 Apr 24
Soligenix to be able to leverage a wide range of financial and regulatory benefits, including government grants for conducting clinical trials, waiver
k855qxee79d65 pqm89vswi
SNGX
15 Apr 24
of financial and regulatory benefits, including government grants for conducting clinical trials, waiver of expensive FDA user fees for the potential
xwbezmqc1r9zkfeg4dwu2
SNGX
11 Apr 24
positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, including government grants for conducting clinical trials
m504axpty543lveo6pqrpd
SNGX
3 Apr 24
as ThermoVax®. To date, this business segment has been supported with government grant and contract funding from the National Institute
ny4b59tc8v1oci
SNGX
15 Mar 24
at December 31, 2023, not including our non-dilutive government funding, we are managing cash burn very carefully in order to achieve our near-term
- Prev
- 1
- Next